Literature DB >> 9049864

Glucocorticoid-induced long-term remission in primary cerebral lymphoma: case report and review of the literature.

B Pirotte1, M Levivier, S Goldman, J M Brucher, J Brotchi, J Hildebrand.   

Abstract

We report a 25-year old immunocompetent woman with a high grade primary non-Hodgkin's lymphoma of the central nervous system (PNHL-CNS) in whom the administration of dexamethasone alone during three months produced a complete clinical and radiological response lasting over four years. If complete remission of PNHL-CNS induced by glucocorticoids are well known, the opportunity to observe glucocorticoid-induced remission for a long period of time without radio- and chemotherapy is rare. Only nine other cases of PNHL-CNS with complete remission induced by glucocorticoids lasting from 6 to 60 months, were found in the literature and are summarized here. Duration of glucocorticoids therapeutic effect in PNHL-CNS is probably underestimated. Glucocorticoids cannot be recommended as sole initial treatment for PNHL-CNS. However, we suggest standard therapies to be delayed in those patients responding completely to glucocorticoids where radio- and chemotherapy should be contraindicated (kidney, liver, bone marrow failure, pregnancy).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9049864     DOI: 10.1023/a:1005733416571

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  33 in total

1.  The effect of massive prednisone and prednisolone therapy on acute leukemia and malignant lymphomas.

Authors:  H M RANNEY; A GELLHORN
Journal:  Am J Med       Date:  1957-03       Impact factor: 4.965

2.  Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma.

Authors:  R J Ott; M Brada; M A Flower; J W Babich; S R Cherry; B J Deehan
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

3.  Spontaneous temporary remission in primary CNS lymphoma.

Authors:  W F Buell; R G Hart
Journal:  Can J Neurol Sci       Date:  1988-02       Impact factor: 2.104

4.  Prognostic factors in the diagnosis and treatment of primary central nervous system lymphoma.

Authors:  I F Pollack; L D Lunsford; J C Flickinger; H L Dameshek
Journal:  Cancer       Date:  1989-03-01       Impact factor: 6.860

5.  Steroid-induced remissions in CNS lymphoma.

Authors:  A Singh; R J Strobos; B M Singh; A B Rothballer; V Reddy; S Puljic; T P Poon
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

6.  Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy.

Authors:  L M DeAngelis; J Yahalom; M H Heinemann; C Cirrincione; H T Thaler; G Krol
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

7.  Primary cerebral lymphoma: an argument for the use of adjunctive systemic chemotherapy.

Authors:  M A Rosenthal; W P Sheridan; M D Green; K Liew; R M Fox
Journal:  Aust N Z J Surg       Date:  1993-01

Review 8.  Primary central nervous system lymphoma.

Authors:  F H Hochberg; D C Miller
Journal:  J Neurosurg       Date:  1988-06       Impact factor: 5.115

9.  Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data.

Authors:  A Boiardi; A Silvani; S Valentini; A Salmaggi; A Allegranza; G Broggi
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

10.  Ghost-cell tumor of the optic chiasm. Primary CNS lymphoma.

Authors:  R S Gray; J J Abrahams; T J Hufnagel; J H Kim; R L Lesser; D D Spencer
Journal:  J Clin Neuroophthalmol       Date:  1989-06
View more
  20 in total

1.  Primary Central Nervous System Lymphoma (PCNSL) occurring in pregnancy.

Authors:  D O'Mahony; A R A Razak; F Brett; L Grogan
Journal:  J Neurol       Date:  2005-07-11       Impact factor: 4.849

Review 2.  New approaches in primary central nervous system lymphoma.

Authors:  Eleanor Fraser; Katherine Gruenberg; James L Rubenstein
Journal:  Chin Clin Oncol       Date:  2015-03

3.  Primary Central Nervous System Lymphoma.

Authors:  Denise M. Damek
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 4.  The Challenge of Primary Central Nervous System Lymphoma.

Authors:  Julia Carnevale; James L Rubenstein
Journal:  Hematol Oncol Clin North Am       Date:  2016-12       Impact factor: 3.722

Review 5.  Primary central nervous system lymphoma: from clinical presentation to diagnosis.

Authors:  U Herrlinger; M Schabet; M Bitzer; D Petersen; P Krauseneck
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 6.  Primary CNS lymphoma: treatment with combined chemotherapy and radiotherapy.

Authors:  L M DeAngelis
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 7.  Glucocorticoid treatment of primary CNS lymphoma.

Authors:  M Weller
Journal:  J Neurooncol       Date:  1999-07       Impact factor: 4.130

Review 8.  Treatment of primary central nervous system lymphoma.

Authors:  Meltem Ekenel; Lisa M DeAngelis
Journal:  Curr Neurol Neurosci Rep       Date:  2007-05       Impact factor: 5.081

9.  A rare case of vomiting: fourth ventricular B-cell lymphoma.

Authors:  C S Hill; A F Khan; S Bloom; S McCartney; D Choi
Journal:  J Neurooncol       Date:  2008-12-18       Impact factor: 4.130

10.  How I treat CNS lymphomas.

Authors:  James L Rubenstein; Neel K Gupta; Gabriel N Mannis; Amanda K Lamarre; Patrick Treseler
Journal:  Blood       Date:  2013-08-20       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.